Rocket Lab's Iridium Deal Collar Tightens as Stock Tests Critical Support Ahead of Q2 Results
Published on 07/14/2026 at 04:52 | Redaktion boerse-global.de
Rocket Lab shares closed Monday at €67.60 in European trading, hovering barely 0.6% above their 200-day moving average of €67.19 — a level that has acted as a technical floor during a turbulent month. The stock has shed 28.4% over the past 30 days and sits roughly 50% below its May high of €133.80, despite a string of operational achievements and a year-over-year gain of 82%. The annualized 30-day volatility has surged above 100%, underscoring just how violently sentiment has swung.
All eyes now turn to August 6, 2026, when Rocket Lab reports second-quarter results. Analysts project revenue between $225 million and $240 million, with a per-share loss of $0.07. The first quarter delivered $200.3 million in revenue, a 63.5% jump from a year earlier, and the backlog stood at $2.2 billion. Investors will scrutinize progress on the Neutron rocket program and the integration roadmap for Iridium Communications, the satellite operator Rocket Lab agreed to buy for roughly $8 billion on June 29.
That acquisition is at the heart of the recent selling pressure. Iridium shareholders are set to receive $54 per share in a combination of cash and Rocket Lab stock, but the deal includes a collar mechanism: as long as Rocket Lab’s stock trades between $67.50 and $112.50, the consideration remains stable. Should the price fall below $67.50, the exchange ratio freezes at 0.4000, reducing the payout’s value. After the stock dipped below $77 in U.S. trading on July 13, the lower boundary suddenly looked vulnerable. Rocket Lab has secured a $3.6 billion bridge loan from Deutsche Bank and Wells Fargo to finance the transaction. Iridium brings 66 low-Earth-orbit satellites, exclusive L-band spectrum, and 2.5 million subscribers, with 2025 revenue of $871.7 million and an EBITDA margin of 57%.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The sell-off on July 13 was not an isolated Rocket Lab story. Shares of SpaceX fell roughly 5%, AST SpaceMobile lost as much as 7.7%, and Intuitive Machines also declined. Market participants pointed to two broad headwinds: China’s first successful landing of a reusable Long March 10B booster on July 10, and a 4.4% oil-price spike to $74.56 a barrel amid tensions in the Strait of Hormuz. Against that backdrop, Rocket Lab executed the VICTUS HAZE mission for the U.S. Space Force, launching a satellite within 16 hours and 42 minutes of notification and completing an orbital rendezvous — a demonstration of responsiveness that Cantor Fitzgerald called a first-of-its-kind capability. The firm reiterated its buy rating with a $96 price target.
Analyst consensus remains broadly bullish. Bank of America rates Rocket Lab a buy with a $115 target, while Citizens sees $130. Of the 27 analysts covering the stock, the average target is $104.73, with a range from $60 to $135. Morgan Stanley recently lifted its bull-case scenario from $185 to $293 and maintains a base case of $105, contingent on an on-time first launch of the Neutron rocket, completion of the Iridium acquisition, and potential awards under the “Golden Dome” defense program.
Technically, the stock is walking a tightrope. The 50-day moving average sits 28.5% above the current price, a gap that signals overextended selling. The relative strength index of 34.5 points to oversold conditions, but the trend remains bearish until the 200-day line — now tested for the first time since the rally began — holds as support. If that level breaks, the next floor could be substantially lower. The coming weeks will show whether the operational momentum that drove Rocket Lab’s year-long ascent can reassert itself, or whether the Iridium collar becomes a tightening noose.
Ad
Rocket Lab Stock: New Analysis - 14 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
